http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2008114487-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate | 2008-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2008114487-A1 |
titleOfInvention | A therapeutic agent for autoimmune skin diseases comprising a polypeptide as an active ingredient |
abstract | An object of the present invention is to provide a novel medicine for autoimmune skin diseases, particularly bullous pemphigoid. A therapeutic agent for autoimmune skin diseases, comprising as an active ingredient a polypeptide that specifically binds to human type XVII collagen and inhibits the binding between human type XVII collagen and autoantibodies thereto. The therapeutic agent for autoimmune skin disease of the present invention uses a polypeptide having a high specificity for the causative factor of the disease, and there is no worry about side effects as compared with conventional therapeutic agents such as steroids. Therefore, it is possible to provide a fundamental treatment for the disease. |
priorityDate | 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.